Lorne Kenneth Abony Pluristem Therapeutics Inc (PSTI) insider trading activity
Lorne Kenneth Abony is Director of PLURISTEM THERAPEUTICS INC. Currently has a direct ownership of 36,750 shares of PSTI, which is worth approximately $25,725. The most recent transaction as insider was on Jan 23, 2024, when has been sold 36,750 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
36.8K
0%
3M change
n/a
12M change
Total Value Held
$25,725
LKA
Lorne Kenneth Abony
Director
Haifa, L3